Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.85 |
| ▸ | PPARG | P37231 | 2/20 | 0.85 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.85 |
| ▸ | MEN1 | O00255 | 2/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.71 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.71 |
| ▸ | PKM | P14618 | 1/20 | 0.71 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.71 |
| ▸ | FLT3 | P36888 | 2/20 | 0.67 |
| ▸ | MAPT | P10636 | 2/20 | 0.67 |
| ▸ | NPC1 | O15118 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 1/20 | 0.67 |
| ▸ | KIT | P10721 | 1/20 | 0.67 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.67 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.67 |
| ▸ | RAB9A | P51151 | 1/20 | 0.67 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.67 |
| ▸ | RELA | Q04206 | 1/20 | 0.67 |
| ▸ | USP2 | O75604 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nevadensin SCHEMBL29155335 | 1.00 | ALDH1A1 (0.85) | ALDH1A1PPARGMAPK1MEN1KMT2A | |
| Gardenin B SCHEMBL1764516 | 0.92 | ALDH1A1 (1.00) | ALDH1A1PPARGMAPK1MEN1KMT2A | |
| SCHEMBL31237871 | 0.92 | ALDH1A1 (0.81) | ALDH1A1PPARGMAPK1MEN1KMT2A | |
| SCHEMBL30683238 | 0.91 | PPARG (0.85) | ALDH1A1PPARGMAPK1MEN1KMT2A | |
| SCHEMBL2180082 | 0.91 | PPARG (0.85) | ALDH1A1PPARGMAPK1MEN1KMT2A | |
| SCHEMBL29449516 | 0.91 | ALDH1A1 (0.88) | ALDH1A1PPARGMAPK1MEN1KMT2A | |
| SCHEMBL4626785 | 0.88 | ALDH1A1 (0.72) | ALDH1A1PPARGMAPK1CYP3A4PKM | |
| SCHEMBL1250942 | 0.87 | ALDH1A1 (0.73) | ALDH1A1PPARGMAPK1MEN1KMT2A | |
| SCHEMBL1764664 | 0.85 | ALDH1A1 (0.86) | ALDH1A1PPARGMAPK1MEN1KMT2A | |
| Sudachitin SCHEMBL6361479 | 0.84 | ALDH1A1 (0.84) | ALDH1A1MAPK1MEN1KMT2ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 238 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12605323-B2 | Composition for inhibiting hair graying, and use thereof | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2026-04-21 | — | — | US | claimed |
| EP-4698662-A2 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | AskBio Inc. (US) | 2026-02-25 | — | — | EP | claimed |
| EP-4615506-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | Sahin, Fikret (TR) | 2025-09-17 | — | — | EP | claimed |
| WO-2024220449-A9 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | AskBio Inc. (US) | 2025-04-03 | — | — | WO | claimed |
| US-20250011393-A1 | FLAVONOID-COLLAGEN CROSSLINKED ANTIOXIDANT HYDROGEL | NORTH CAROLINA STATE UNIVERSITY | 2025-01-09 | — | — | US | claimed |
| WO-2024258363-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | SAHIN FIKRET (TR) | 2024-12-19 | — | — | WO | claimed |
| WO-2024220449-A2 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | ASKLEPIOS BIOPHARMACEUTICAL, INC. (US) | 2024-10-24 | — | — | WO | claimed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| US-20240099344-A1 | HYDROXY- AND METHOXY-SUBSTITUTED FLAVONOIDS AND THEIR USE | FIRMENICH SA (CH) | 2024-03-28 | — | — | US | claimed |
| US-20230330120-A1 | COMPOSITION FOR PREVENTING HAIR LOSS OR PROMOTING HAIR REGROWTH | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2023-10-19 | — | — | US | claimed |
| CN-104869848-A | Increasing the bioavailability of flavan-3-ols by polyphenols | NESTEC SA | 2015-08-26 | — | — | CN | claimed |
| CN-104502479-A | Quality detection method of preparation for treating tracheitis and bronchitis | GUIZHOU PROVINCE KEHUI PHARMACEUTICAL FACTORY | 2015-04-08 | — | — | CN | claimed |
| WO-2014083172-A1 | INCREASING THE BIOAVAILABILITY OF FLAVAN-3-OLS BY POLYPHENOLS | NESTEC S.A. (CH) | 2014-06-05 | — | — | WO | claimed |
| CN-101723768-B | Method for carrying out hydroxyethylation on phenolic acid compounds and products thereof | KEY LAB OF CHEMISTRY FOR NATURAL PRODUCTS OF GUIZHOU PROVINCE AND CHINESE ACADEMY OF SCIENCES | 2013-12-25 | — | — | CN | claimed |
| CN-103472143-A | Cold-curing preparation and detection method for intermediate product | GUIZHOU BAILING GROUP PHARMACEUTICAL CO LTD | 2013-12-25 | — | — | CN | claimed |
| US-20120315332-A1 | PHARMACEUTICAL COMPOSITION INCLUDING SUNFLOWER EXTRACT, PREPARATIVE METHOD AND USE THEREOF | PEIXUE LING (CN) | 2012-12-13 | — | — | US | claimed |
| EP-2520305-A1 | MEDICINAL COMPOSITION INCLUDING SUNFLOWER EXTRACT, PREPARATIVE METHOD AND USE THEREOF | Ling, Peixue (CN) | 2012-11-07 | — | — | EP | claimed |
| CN-102018740-B | Pharmaceutical composition containing sunflower leaf extract and use thereof | PEIXUE LING | 2012-05-23 | — | — | CN | claimed |
| CN-102018740-A | Medicinal composition containing extracts of leaves of helianthus and application of the same | PEIXUE LING | 2011-04-20 | — | — | CN | claimed |
| CN-101723768-A | Method for carrying out hydroxyethylation on phenolic acid compounds and products thereof | KEY LAB OF CHEMISTRY FOR NATUR | 2010-06-09 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120315332-A1 | PHARMACEUTICAL COMPOSITION INCLUDING SUNFLOWER EXTRACT, PREPARATIVE METHOD AND USE THEREOF | HMGCR, LSS, CYP8B1 | ALDH1A1 1355/4885PPARG 513/4885MAPK1 3631/4885 |
| US-12605323-B2 | Composition for inhibiting hair graying, and use thereof | CTNND1, CTNNB1, GSK3B | ALDH1A1 3922/4885PPARG 4247/4885MAPK1 1537/4885 |
| US-20230330120-A1 | COMPOSITION FOR PREVENTING HAIR LOSS OR PROMOTING HAIR REGROWTH | WNT1, WNT3A, WNT3 | ALDH1A1 1463/4885PPARG 1159/4885MAPK1 1987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.